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A B S T R A C T
Little information is available regarding distribution of HPV types in different histological subtypes of adenocar-
cinoma (AC). Thus, in this study we examined the frequency of high-risk (hr) HPV types in AC, adenocarcinoma in situ
(AIS) and adenosquamous carcinoma (ADSQ). A total of 102 cases of primary cervical adenocarcinoma (26 AIS and 76
invasive AC) obtained from pathology files from 1995–2006 were histologically subtyped. Our results demonstrated that
endocervical type occupied the major subtype of AC (22/66) followed by ADSQ (17/66) where as in the group of AIS
endocervical type (12/23) was followed by intestinal type of AIS (7/23). Successful DNA extraction was obtained in 89
samples; 81 out of 89 (91.0%) tested positive for HPV DNA. The prevalence of HPV DNA in AIS, AC and ADSQ was
91.3% (21/23), 90.9% (60/66) and 94.1% (16/17), respectively. We found HPV 18 type to be the most predominant type in
AIS (11/21) and AC (17/60) followed by HPV of undeternmined type in AIS (3/21) and HPV 16 in AC (9/60) as the sole vi-
ral type. HPV 18 was most frequently detected type in all histological subtypes of AIS and AC. We have detected HPV
DNA in all 5 samples of clear cell carcinoma (CCC), although other studies have reported a highly variable prevalence of
HPV DNA in CCC. The most prevalent HPV type in ADSQ was HPV-16 followed by HPV 33 as single type. The observed
overall predominance of HPV 18 in AIS (2 = 6.109, p£ 0.025) and AC (2 = 8.927, p£0.01) as well as of HPV 16 in ADSQ
(2 = 10.164, p £ 0.01) was statistically significant. Our data revealed statistically significant predominance of single
hrHPV infections in AIS (16/21; 2 = 11.523, p £ 0.001) and AC (37/60; 2 = 6.533, p £ 0.025) whereas multiple hrHPV
infections were more abundant in AC comparing to AIS (23/81and 5/81, respectively; 2 = 13.989, p £ 0.001).
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Introduction
There are two major histological types of invasive cer-
vical cancer: squamous cell carcinoma (SCC) and ade-
nocarcinoma (AC). Incidence rate of SCC has been de-
clining in recent years1 but unfortunately incidence of
cervical AC is increasing in developed countries, despite
their widespread screening programmes. Recent reports
indicated that AC accounts for approximately 20–25% of
uterine cervical cancer compared with only 5–15% in the
past2. Many countries report steady increase in incidence
rates especially among younger women, since early 1970s2–6.
Although effective screening programmes contribute to
decreasing incidence rates of SCC but neither improved
surveillance or classification of ACs appears to account
for all of the increase in ACs. There are more than 40
HPV types known to infect female genital tract, and a
subset of at least 15 of these are known to have a strong
oncogenic potential11. Therefore, HPV types have been
classified according to their association with cervical can-
cer and precursor lesions into oncogenic or high-risk (hr)
and low-risk (lr) HPV types12. Cervical squamous neopla-
sia has shown to be strongly associated with hrHPV in-
fection with studies showing more than 90% of cancers
containing HPV DNA13,14. Although, association of hrHPV
with cervical AC has been studied less extensively, re-
ports in the past decade indicate similar association, sug-
gesting causal relationship between hrHPV and cervical
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AC15,16. Major limitation is that number of patients with
cervical ACs involved in these studies was small. Another
reason why causal relationship between HPV infection
and cervical AC is further complicated is the fact that AC
encompasses several heterogeneous histological subtyp-
es. The majority of tumours are mucionus AC including
endocervical and intestinal type, while minor component
of cervical AC includes variety of histological subtypes
such as endometrioid, clear cell serous, villoglandular,
minimal deviation, mesonephric adenocarcinoma and mix-
ture of those subtypes. Specific histological subtype is
clear cell carcinoma (CCC) which accounts for 2–7% of
cervical AC and if presenting in young patients usually
involves association with diethylstilbestrol (DES) expo-
sure in utero17,18 and HPV DNA negativity. Other pa-
tients with CCC have no known risk factors and occur in
an older age group18.
While hrHPV infection appears to be required for the
development of both SCC and AC, the distribution of
hrHPV types seen in these two forms of disease varies
from study to study. Whereas HPV 16 is the most fre-
quently involved in the development of SCC, HPV 18
alone or in combination with HPV 16 is reported to be a
predominant type in AC19 and adenocarcinoma in situ
(AIS). Little information is available regarding geogra-
phic variation of HPV types in different histological sub-
types of AC. Herein we conducted a retrospective study
in order to evaluate the frequency of HPV types in
adenocarcinoma in situ (AIS), AC and adenosquamous
carcinoma (ADSQ).
Materials and Methods
Case selection and histological subtyping
A total of 102 specimens of primary cervical adeno-
carcinoma were (26 AIS and 76 invasive AC) obtained
from the Department of Pathology, University of Rijeka,
Croatia, which were collected from 1995 to 2006. Paraf-
fin embedded sections of cone or hysterectomy specimens
were reviewed by two pathologists. Each case was his-
tologically subtyped according to the standard histo-
logical criteria20 and associated lesions of the squamous
epithelium were recorded as well. Endocervical type was
the most common invasive adenocarcinoma, found in 22
cases, followed by adenosquamous carcinoma (17 cases),
intestinal (12 cases), and endometrioid type (8 cases).
Five cases were diagnosed as clear cell carcinoma, 3 cases
were signet-ring carcinoma, 3 cases as serous and one
case as villoglandular and glassy cell carcinoma. Mixed
mucinous adenocarcinoma was found in 4 cases. Associ-
ated CIN I–III lesions were found in 11 cases. According
to morphological criteria 15 AIS were suptyped as endo-
cervical, 7 cases as intestinal, 2 cases as endometrioid
and one as adenoaquamous and mixed type. Depending
on tissue availability, successful DNA extraction, defined
by presence of -globin gene sequence, was found in 89
samples, 3 cases of AIS and 10 cases of AC were excluded
from further analysis.
DNA extraction and PCR analysis
Total DNA was isolated from formalin fixed, paraffin
embedded samples. Great care was taken on sample sec-
tioning to avoid any contamination between the samples.
Depending on the amount of biopsy material embedded
in paraffin, 4–10 sections (5 m thick) were placed in a
microcentrifuge tube. The sections were deparaffinized
by adding 1 mL of xylene and heating at 55°C for 30 min-
utes, followed by centrifugation and subsequent removal
of the supernatant. Upon dewaxing with three washes of
xylene, 1 mL of 100% ethanol was added to remove resid-
ual xylene. The tissues were dried at 37°C for 30 minutes
and DNA was isolated using NucleoSpinTissue kit (Ma-
charey-Nagel, Duren, Germany) according to the manu-
facturer’s instructions.
Detection of HPV DNA was performed using E6 and
E7 consensus primers (Human Papillomavirus Typing
Set, Takara Biomedicals, Japan). The HPV types in posi-
tive samples were further characterized by using type
specific primers amplifying sequences of HPV 16, 18 and
33 within E6 and E7 open reading frame (ORF) (Human
Papillomavirus Detection Set, Takara Biomedicals, Ja-
pan) and HPV 31, 45, 52, 59 and 68 in the E7 ORF14.
Statistical analysis
HPV prevalence was expressed as percentage of all
cases tested for HPV in different histological groups of
AC (accounted only once). The overall prevalence of indi-
vidual hrHPV types was determined as they appeared as
either single or within multiple infections. Multiple hrHPV
infection was defined as two or more hrHPV types. The
differences of the means of the continuous variables were
analyzed with the Student’s t-test and the distribution of
non-continuous histological variables versus HPV status
was analyzed with the Chi-square test (	2). P values of
<0.05 were used as the cut-off for statistical significance.
Results
As shown in Table 1. endocervical type represented
the major subtype of AC (22/66) followed by ADSQ (17/66)
where as in the group of AIS endocervical type (12/23)
was followed by intestinal type of AIS (7/23). The average
age of patients with AIS, AC and ADSQ was 41.82, 48.9
and 44, respectively. Statistical analysis revealed that av-
erage age of the patients with AIS and AC (41.82 years
versus 48.9 years) was significantly different (Student’s
t-test; t=2.55, degrees of freedom 87, p£0.05). Looking at
different histological subtypes the average age of pa-
tients with intestinal AC and AIS was the youngest (35.8
and 39.28 years respectively). Cervical intraepithelial
neoplasia (CIN), ranging from CIN I to CIN III accompa-
nied AIS and AC in 27 cases (16/23 and 11/66, respec-
tively).
We were able to successfully extract DNA from 89
samples and 81 (91.0%) tested positive for HPV DNA.
HPV DNA prevalence according to different histological
subtypes of AC, AIS and ADSQ is presented in Table 1.
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The prevalence of HPV DNA in AIS, AC and ADSQ was
91.3% (21/23), 90.9% (60/66) and 94.1% (16/17), respec-
tively. We have detected HPV DNA in all 5 samples of
CCC although other studies have reported a highly vari-
able prevalence of HPV DNA in CCC17,18,21. Also, patients
with CCC belong to oldest age group (63.8 years) com-
pared to all other histological subtypes of AC (Table 1).
While HPV types 16, 18, 31 and 33 were detected in
single or multiple infections we did not detect HPV types
45, 52, 59 and 68 in any tested samples. All samples that
were HPV DNA positive but were not typed as HPV 16,
18, 31, 33, 45, 52, 59 or 68 were marked as HPV X. We
found HPV 18 type to be the most predominant type in
AIS (11/21) and AC (17/60) followed by HPV X in AIS
(3/21) and HPV 16 in AC (9/60) as the sole viral type (Ta-
ble 2). Also, HPV 18 was most frequently detected type in
all histological subtypes of AIS and AC. On the other
hand the most prevalent HPV type in ADSQ was HPV 16
followed by HPV 33 as single type. The observed overall
predominance of HPV 18 in AIS (	2= 6.109, p£ 0.025)
and AC (	2=8.927, p£0.01) and of HPV 16 in ADSQ
(	2=10.164, p£0.01) was statistically significant (Table 3).
When we analysed the distribution of HPV 16 and 18
in endocervical AIS and AC together we found statisti-
cally significant prevalence of HPV 18 (21/31; 	2=6.458,
p£0.025). Also, prevalence of HPV 18 in intestinal AIS
and AC was statistically significant (9/11; 	2=4.701, p£
0.05) (Table 3). However, there is no statistically signifi-
cant prevalence of HPV 18 in remaining histological sub-
types of AIS and AC.
Combining together single and multiple HPV infec-
tions, HPV 18 was detected in 68.2% of AC (30/44) and
66.7% of all AIS (14/21) cases whereas HPV 16 in 36.4%
(16/44) and 28.6% (6/21), respectively. Single HPV type
infections were statistically significant in AIS (16/21;
	
2=11.523, p£0.001) and AC (37/60; 	2=6.533, p£0.025)
while equal number of single and multiple HPV infec-
tions was detected in ADSQ (8/16). However we found
statistically significant higher number of multiple infec-
tions in AC compared to AIS (23/81and 5/81, respec-
tively; 	2=13.989, p£0.001).
Discussion
When we examined the number of AC cases diagnosed
at our Department of pathology (which covers large re-
gion of Rijeka county), we noticed increasing trend of
glandular cervical carcinomas during 1995–2006 period
of time with predominant number of cases in women
29–49 years of age (data not shown). These data are in
accordance with increasing trend of this neoplasia seen
in developed countries2,6.
It is well established that hrHPV is causal factor in
development of SCC and its precursor lesions22 with
studies reporting almost 100% prevalence of HPV in
SCC11,13,23. However, causal linkage of HPV infection to
the cervical AC has not been considered as strong as it is
for SCC due to more variable and generally lower HPV
prevalence rates (60%–96%)18,19,22,24–26. Recent more sen-
sitive extraction and detection techniques have made it
possible to identify the higher rate of HPV infection in
I. Had`isejdi} et al.: HPV in Different Histological Subtypes of Cervical Adenocarcinoma, Coll. Antropol. 31 (2007) Suppl. 2: 97–102
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Endocervical 22 26–74 48.59 6 27.3 2 9.1 20 90.9 15 75 5 25
Intestinal 5 30–40 35.8 1 20 1 20 4 80 2 50 2 50
Endometrioid 8 29–82 54.37 – – – – 8 100 4 50 4 50
Clear cell 5 42–73 63.8 – – – – 5 100 4 80 1 20
Serous 3 38–78 55.67 1 33.3 2 66.7 1 33.3 1 100 – –
Villoglandular 1 40 40 – – – – 1 100 1 100 – –
Mixed 4 37–69 48.75 1 25 – – 4 100 2 50 2 50
Glassy cell 1 65 65 – – – – 1 100 – – 1 100
Adenosqumaous 17 21–73 44 2 11.8 1 5.9 16 94.1 8 50 8 50
All invasive adenocarcinoma 66 21–82 48.9 1 116.7 6 9.1 60 90.9 37 61.7 23 38.3
Endocervical 12 26–56 45.5 10 83.3 1 8.3 11 91.7 7 58.3 4 33.3
Intestinal 7 30–46 39.28 5 71.4 – – 7 100 6 85.7 1 14.3
Mixed 1 40 40 1 100 – – 1 100 1 100 – –
Adenosqumaous 1 47 47 – – – – 1 100 1 100 – –
Endometrioid 2 43 43 – – 1 16.7 1 50 1 100 – –
All adenocarcinoma in situ 23 26–56 41.82 16 69.6 2 8.7 21 91.3 16 76.2 5 23.8
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AC with frequencies reaching 85% or more18,27. Although
DNA extractions from older (>10 years) paraffin embed-
ded tissue blocks can be sometimes cumbersome we were
able to detect HPV DNA in large majority of cases (91%)
consistent with previous findings18,28. We screened our
samples for only 8 hrHPV types because combined to-
gether, as we showed previously29, they cover almost 90%
of overall HPV type found in cervical carcinoma.
I. Had`isejdi} et al.: HPV in Different Histological Subtypes of Cervical Adenocarcinoma, Coll. Antropol. 31 (2007) Suppl. 2: 97–102
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Endocervical 20 3 15 10 50 1 5 – – 1 5 2 10 1 5 – – – – – – 2 10
Intestinal 4 – 2 50 – – – – – – 2 50 – – – – – – – – – –
Endometrioid 8 – 2 25 – – – – 2 25 1 12.5 1 12.5 – – – – – – 2 25
Clear cell 5 – 2 40 – – 1 20 1 20 – – – – – – – – – – 1 20
Serous 1 – – – 1 100 – – – – – – – – – – – – – – – –
Villoglandular 1 – 1 100 – – – – – – – – – – – – – – – – – –
Mixed 4 1 25 – – – – – – 1 25 1 25 – – – – – – – – 1 25
Glassy cell 1 – – – – – – – – – – – – – 1 100 – – – – – –
Adenosqumaous 16 5 31.3 – – – – 3 18.7 – – 1 6.3 – – – – 1 6.3 3 18.7 3 18.7
All invasiveadeno-
carcinoma
60 9 15 17 28.3 2 3.3 4 6.7 5 8.3 7 11.7 2 3.3 1 1.7 1 1.7 3 5 9 15
Endocervical 11 1 9.1 4 36.3 – – – – 2 18.2 1 9.1 1 9.1 – – 1 9.1 – – 1 9.1
Intestinal 7 1 14.3 4 57.1 – – – – 1 14.3 – – – – – – – – – – 1 14.3
Mixed 1 – 1 100 – – – – – – – – – – – – – – – – – –
Adenosqumaous 1 – 1 100 – – – – – – – – – – – – – – – – – –
Endometrioid 1 – 1 100 – – – – – – – – – – – – – – – – – –
All adenocarcinoma
in situ
21 2 9.5 11 52.3 – – – – 3 14.3 1 4.8 1 4.8 – – 1 4.8 – – 2 9.5
HPV – human papillomavirus, *Includes HPV types other than 16, 18, 31, 33, 45, 52, 59, 68; **Includes multiple high risk HPV infec-
tions (HPV 18, 16 &31, HPV 18, 16 & 33, HPV 16, 31 &33, HPV 16, 18, 31 &33)
TABLE 3














Endocervical 20 7 35 15 75 3 15 2 10 1 5
Intestinal 4 2 50 4 100 – – – – – –
Endometrioid 8 3 37.5 5 62.5 3 37.5 2 25 2 25
Clear cell 5 1 20 3 60 – – 2 40 1 20
Serous 1 – – – – 1 100 – – – –
Villoglandular 1 – – 1 100 – – – – – –
Mixed 4 3 75 1 25 1 25 1 25 1 25
Glassy cell 1 – – 1 100 – – 1 100 – –
All invasive adenocarcinoma 44 16 36.4 30 68.2 8 18.2 8 18.2 5 11.4
Adenosquamous 16 13 81.3 4 25 3 18.7 8 50 – –
Endocervical 11 4 36.4 6 54.5 2 18.2 1 9.1 2 18.2
Intestinal 7 2 28.6 5 71.4 1 14.3 1 14.3 1 14.3
Mixed 1 – – 1 100 – – – – – –
Adenosquamous 1 – – 1 100 – – – – – –
Endometrioid 1 – – 1 100 – – – – – –
All adenocarcinoma in situ 21 6 28.6 14 66.7 3 14.3 2 9.5 3 14.3
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HPV infection is required for the development of both
SCC and AC, however, distribution of HPV types seen in
these two forms of the diseases differ. HPV 16 type is the
most frequently involved in the development of SCC30 of
the cervix where as studies describing HPV type preva-
lence in AC are in disagreement. Some report HPV 16
and HPV 18 type to have equal prevalence30,18, while oth-
ers show predominance of HPV 18 in AC26. In this study
we found that, in overall, HPV 18 statistically signifi-
cantly prevails in AIS and AC, while in ADSQ HPV 16 is
the most frequent type. We found HPV 18 predominantly
in endocervical and intestinal AIS and AC, however there
is no statistically significant prevalence of HPV 18 in re-
maining histological subtypes of AIS and AC. Large
meta-analysis study16 showed that the highest risks of
developing AC were associated with HPV 18 (OR=410)
followed by HPV 16 (OD=164). In context of these find-
ings our results support the hypothesis of HPV 18 being
the most important risk factor in developing of cervical
AC. Existing data on the HPV DNA detection in cervical
CCCs are opposing, with some studies indicating HPV
DNA presence17,21,28, while others were unable to identify
HPV DNA18,31. In our study we found all 5 CCC cases to
be HPV DNA positive. Therefore our results are in line
with those that reported positive findings but exact cause
for the discrepancy in the HPV DNA detection from
CCCs is still unclear.
Our data revealed statistically significant predomi-
nance of single hrHPV infections in AIS and AC, how-
ever, other studies showed similar results only for AC18,27.
Presented results support hypothesis of Zielinski et al.27
that invasive growth of glandular epithelial cells is trig-
gered by the action of a single HPV type rather than a po-
tentially synergistic action of multiple HPVs. However,
in our study we found rather high prevalence of multiple
HPV infections in AIS and invasive AC, 23.8% and 38.2%
cases respectively (Table 1), that can not be overlooked.
The fact that multiple infections are even more abun-
dant in invasive AC than in the precursor lesion, might
indicate that multiple infection could contribute to can-
cer development in a more aggressive way than a single
infection with hrHPV.
Conclusion
Our study revealed that the most prevalent hrHPV
type in AIS and AC is HPV 18 while HPV 16 is predomi-
nant type in ADSQ. Analysis of various histological sub-
types of AIS and AC demonstrate that in endocervical
and intestinal carcinoma HPV 18 is predominant type,
whereas in remaining histological subtypes such pre-
dominance was not detected. We have detected HPV
DNA in all 5 samples of CCC although other studies have
reported a highly variable prevalence of HPV DNA in
CCC. Our data revealed statistically significant predomi-
nance of single hrHPV infections in AIS and AC whereas
multiple hrHPV infections were more abundant in AC
comparing to AIS.
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RASPODJELA TIPOVA HUMANOG PAPILOMAVIRUSA U RAZLI^ITIM HISTOLO[KIM
SUPTIPOVIM ADENOKARCINOMA VRATA MATERNICE
S A @ E T A K
Budu}i da su podaci u svijetu o prevalenciji HPV tipova u razli~itim histolo{kim suptipovma adenokarcinoma (AC)
vrlo oskudni, proveli smo ovu studiju s ciljem da ispitamo prevalencije HPV tipova u AC, adenokarcinomu in situ (AIS) i
adenoskvamoznom karcinomu (ADSQ) u Hrvatskoj. Ukupno 102 arhivska uzoraka primarnog adenokarcinoma vrata
maternice (26 AIS i 76 AC), prikupljeno je na patologiji tijekom 1995–2006, i histolo{ki suptipizirano. Dobiveni podaci
su pokazali da je najzastupljeniji suptip AC endocervikalni (22/66), zatim ADSQ (17/66), dok je u AIS-u endocervikalni
suptip utvr|en u 12/23, a intestinalni u 7/23 AIS-a. DNK je uspje{no izolirana iz 89 uzoraka. U 81 uzorku (91%) do-
kazana je HPV DNK. Utvr|ena je HPV DNK prevalencija u AIS-u 91,3%, u AC 90,9 % i ADSQ 94,1%. U slu~ajevima
infekcije samo jednim tipom utvrdili smo da je HPV 18 naju~estaliji u AIS-u (11/21) i AC (17/60), a slijede ih grupa
neodre|enog tipa HPV-a u AIS-u (3/21) te HPV 16 u AC (9/60). HPV 18 je i naju~estaliji genotip u svim histolo{kim
suptipovima AIS-a i AC. Tako|er smo dokazali HPV DNK u svih 5 uzoraka karcinoma svjetlih stanica (CCC) iako su
druge studije pokazale razli~ite podatke o prevalenciji HPV DNK u CCC. Naju~estaliji pojedina~ni HPV tipovi u ADSQ
su HPV 16 i HPV 33. Dokazano je da je ukupna prevalencija HPV 18 u AIS-u i AC, te HPV 16 u ADSQ statisti~ki
zna~ajna; HPV 18 u AIS-u (	2 = 6.109, p £ 0.025) i AC (	2 = 8.927, p£0.01) i HPV 16 u ADSQ (	2 = 10.164, p £ 0.01).
Infekcija s jednim HPV tipom je statisti~ki zna~ajno u~estalija u AIS-u (16/21; 	2 = 11.523, p £ 0.001) i AC (37/60; 	2 =
6.533, p £ 0.025), dok je vi{estruka HPV infekcija u~estalija u AC-u u odnosu na AIS (23/81 i 5/81, 	2 = 13.989, p £
0.001).
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